16768-98-2

Basic information

• Product Name: ethyl 4-(3-methoxyphenylthio)-3-oxobutanoate
• Synonyms: ethyl 4-(3-methoxyphenylthio)-3-oxobutanoate;Butanoic acid, 4-[(3-methoxyphenyl)thio]-3-oxo-, ethyl ester
• CAS NO: 16768-98-2
• Molecular Formula: C₁₃H₁₆O₄S
• Molecular Weight: 268.32874
• Mol File: 16768-98-2.mol
• Article Data: 6

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ethyl 4-(3-methoxyphenylthio)-3-oxobutanoate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-(3-methoxyphenylthio)-3-oxobutanoate(16768-98-2)
• EPA Substance Registry System: ethyl 4-(3-methoxyphenylthio)-3-oxobutanoate(16768-98-2)

Safety Data

• Hazardous Substances Data: 16768-98-2(Hazardous Substances Data)

Upstream product

• 638-07-3 ethyl (2-chloroaceto)acetate 
• 15570-12-4 3-methoxybenzenethiol 

Downstream Products

• 886059-58-1 5-hydroxy-2-(3-methoxy-phenylsulfanylmethyl)-1-methyl-1H-indole-3-carboxylic acid ethyl ester 
• 886059-71-8 5-hydroxy-2-(3-methoxy-benzenesulfinylmethyl)-1-methyl-1H-indole-3-carboxylic acid ethyl ester 
• 886059-76-3 5-hydroxy-2-(3-methoxy-benzenesulfonylmethyl)-1-methyl-1H-indole-3-carboxylic acid ethyl ester 

Relevant articles and documents

CARBOXYLIC ACID COMPOUNDS IN TREATMENT OF DIABETES MELLITUS

The invention relates to compounds for increasing GPR40 recetpor activity and application thereof. These compounds include of a compound of Formula (I), pharmaceutically acceptable salts thereof, solvates thereof, isomers thereof, or produgs of the compou

Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 5-hydroxy-1H-indole-3-carboxylates

A series of ethyl 5-hydroxy-1H-indole-3-carboxylates 6A-10 T were synthesized and evaluated for their anti-hepatitis B virus (HBV) activities in 2.2.15 cells. The IC50 and selective index of inhibition on replication of HB

BICYCLIC DERIVATIVES AS PPAR MODULATORS

The present invention is directed to compounds represented by the following structural formula, Formula (I), and stereoisomers, pharmaceutically acceptable salts, solvates and hydrates thereof, wherein: (a) R2 is selected from the group consisting of C0-C8 alkyl and C1-4- heteroalkyl; (b) X is selected from the group consisting of a single bond, O, S, S(O)2 and N; (c) U is an aliphatic linker wherein one carbon atom of the aliphatic linker is optionally replaced with O, NH or S, and wherein such aliphatic linker is optionally substituted with from one to four substituents each independently selected from R30; (d) Y is selected from the group consisting of C, O, S, NH and a single bond; and (e) E is C(R3)(R4)A or A.